Format

Send to:

Choose Destination
See comment in PubMed Commons below
Dev Disabil Res Rev. 2010;16(3):265-72. doi: 10.1002/ddrr.119.

Pharmacotherapy of disruptive behavior in mentally retarded subjects: A review of the current literature.

Author information

  • 1Department of Child and Adolescent Neuropsychiatry, University of Rostock, Rostock, Germany. frank.haessler@med.uni-rostock.de

Abstract

The review presented here describes the state of the art of pharmacological treatment of aggression in subjects with mental retardation (MR) summing up results for both, children and adults. In general, psychopharmacological treatment of disruptive behavior in individuals with MR is similar to the treatment in subjects without MR. Compared to individuals without MR medication should "start lower and go slower." For children and adults results were similar but were obtained by somewhat different medications. There is evidence for the conventional antipsychotic zuclopenthixol having positive effects on disruptive behavior. Most studies described the atypical antipsychotic risperidone to control severe self-injurious behavior and other behavior problems in a variety of diagnoses. Anticonvulsants, antidepressants, and anxiolytic medications are reported as effective as well for the treatment of individuals with disruptive behavior. Aggression-related behavior often gets treated with stimulants or with stimulants combined with atypical neuroleptics.

PMID:
20981765
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk